Biomerica (BMRA) Equity Average (2016 - 2026)
Biomerica's Equity Average history spans 16 years, with the latest figure at $3.9 million for Q1 2026.
- On a quarterly basis, Equity Average fell 27.2% to $3.9 million in Q1 2026 year-over-year; TTM through Feb 2026 was $3.9 million, a 27.2% decrease, with the full-year FY2025 number at $5.3 million, down 41.6% from a year prior.
- Equity Average hit $3.9 million in Q1 2026 for Biomerica, down from $4.8 million in the prior quarter.
- Over the last five years, Equity Average for BMRA hit a ceiling of $11.2 million in Q3 2023 and a floor of $3.9 million in Q1 2026.
- Historically, Equity Average has averaged $7.2 million across 5 years, with a median of $7.2 million in 2024.
- Biggest five-year swings in Equity Average: soared 35.11% in 2023 and later tumbled 48.09% in 2024.
- Tracing BMRA's Equity Average over 5 years: stood at $7.8 million in 2022, then rose by 29.46% to $10.1 million in 2023, then tumbled by 48.09% to $5.2 million in 2024, then decreased by 8.32% to $4.8 million in 2025, then dropped by 19.17% to $3.9 million in 2026.
- Business Quant data shows Equity Average for BMRA at $3.9 million in Q1 2026, $4.8 million in Q4 2025, and $4.6 million in Q3 2025.